Access

Letter


Nature Medicine 10, 1234 - 1239 (2004)
Published online: 3 October 2004 | doi:10.1038/nm1114

TCR affinity and negative regulation limit autoimmunity

Matthew A Gronski1, Jonathan M Boulter2, Demetrius Moskophidis3, Linh T Nguyen1, Kaisa Holmberg4, Alisha R Elford1, Elissa K Deenick1, Hee O Kim4, Josef M Penninger5, Bernhard Odermatt6, Awen Gallimore2, Nicholas R J Gascoigne4 & Pamela S Ohashi1


Autoimmune diseases are often mediated by self-reactive T cells, which must be activated to cause immunopathology. One mechanism, known as molecular mimicry, proposes that self-reactive T cells may be activated by pathogens expressing crossreactive ligands1, 2, 3. Here we have developed a model to investigate how the affinity of the T-cell receptor (TCR) for the activating agent influences autoimmunity. Our model shows that an approximately fivefold difference in the TCR affinity for the activating ligand results in a 50% reduction in the incidence of autoimmunity. A reduction in TCR-ligand affinity to approximately 20 times lower than normal does not induce autoimmunity despite the unexpected induction of cytotoxic T lymphocytes (CTLs) and insulitis. Furthermore, in the absence of a key negative regulatory molecule, Cbl-b4, 5, 100% of mice develop autoimmunity upon infection with viruses encoding the lower-affinity ligand. Therefore, autoimmune disease is sensitive both to the affinity of the activating ligand and to normal mechanisms that negatively regulate the immune response.


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

A Toll-like trigger for autoimmune disease

Nature Medicine News and Views (01 Feb 2005)

Juvenile autoimmune diabetes: A pathogenic role for maternal antibodies?

Nature Medicine News and Views (01 Apr 2002)

See all 3 matches for News And Views
$rb.Type.Code